// App-Quantinova.ai

5261 : Linear ongoing risk of major cardiovascular events in a global prospective registry of high-risk patients with stable coronary disease: insights from the TIGRIS study

Researchers

Presenter

  • D Brieger

Principal Investigators

  • S J Pocock

  • S G Goodman

  • D Westermann

  • S Blankenberg

  • J C Nicolau

  • J Y Chen

  • C B Granger

  • R Grieve

  • S Yasuda

Medical Centers

  • Concord Hospital, Anzac Research Institute, Sydney, Australia

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Canada

  • University Cancer Center Hamburg (UCCH), Hamburg, Germany

  • Instituto da Crianca, FMUSP, Sao Paulo, Brazil

  • Guangdong General Hospital Guangdong Cardiovascular Institute, Provincial Key Laboratory of Coronary Disease, Guangzhou, China People's Republic of

  • Duke Clinical Research Institute - Durham - United States of America

  • National Cerebral and Cardiovascular Center, Suita, Japan

Locations

  • Australia

  • United Kingdom

  • Canada

  • Germany

  • Brazil

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved